- Home
- NEXR vs IMCC Comparison
NEXR vs IMCC Comparison
Compare NEXR & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEXR | IMCC |
|---|---|---|
| Founded | 2021 | 1980 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 953.3K | 1.0M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NEXR | IMCC |
|---|---|---|
| Price | $1.04 | $1.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 247.5K | ★ 5.0M |
| Earning Date | 08-14-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $60.66 |
| Revenue Next Year | N/A | $6.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.09 |
| 52 Week High | $5.28 | $8.65 |
Technical Indicators
Market Signals| Indicator | NEXR | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 33.54 | 46.96 |
| Support Level | $0.23 | $0.46 |
| Resistance Level | $1.95 | $4.15 |
| Average True Range (ATR) | 0.16 | 0.84 |
| MACD | -0.05 | -0.18 |
| Stochastic Oscillator | 8.56 | 3.34 |
Price Performance
Historical ComparisonAbout NEXR Nexera Technologies Ltd Ordinary Shares
Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.